Skip to content

Effects of computerized cognitive training on the elderly with reversible cognitive frailty in nursing homes : a randomized controlled trial

Effects of computerized cognitive training on the elderly with reversible cognitive frailty in nursing homes : a randomized controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300068132
Enrollment
Unknown
Registered
2023-02-08
Start date
2023-05-01
Completion date
Unknown
Last updated
2023-07-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cognitive frailty

Interventions

Control group:Multi-cognitive-domain cognitive training
Experimental group:Single-cognitive domain memory training

Sponsors

School of Nursing, Southern Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
60 Years to 90 Years

Inclusion criteria

Inclusion criteria: 1.Aged = 60 years old; 2. Continue to live in the pension institution for at least 3 months; 3.Reversible cognitive frailty: physical frailty (including pre-physical frailty) and cognitive impairment, in which physical frailty was judged by Fried scale score 1-5, and cognitive impairment was judged by Montreal Cognitive Assessment scale MoCA = 25; 4.Complaints of cognitive decline (mainly memory); 5.Regular exercise in the last six months.  All inclusion criteria are met before inclusion.

Exclusion criteria

Exclusion criteria: 1.Hypertensive patients with uncontrollable blood pressure (systolic blood pressure greater than 160mmHg or diastolic blood pressure greater than 100mmHg); 2.History of alcohol and drug abuse; 3.Have a history of mental illness (such as personality disorder, schizophrenia, depression, etc.), or severe aphasia and audio-visual disorders, or severe organ failure, history of ventricular infarction, history of coronary heart disease, musculoskeletal disorders and other exercise contraindications; 4.Use of drugs that affect cognitive function (chololine enzyme inhibitors, memantine hydrochloride, cabalatine, antipsychotics, etc.) 5.Unwilling to participate in this study; 6.Participating in other clinical study and will affect the evaluation of the results of this study. Any of the above conditions are excluded from the study.

Design outcomes

Primary

MeasureTime frame
reversal rate of cognitive frailty;global cognitive function;frailty;

Secondary

MeasureTime frame
physical function;memory and attention;executive function;quality of life;

Countries

China

Contacts

Public ContactGao Yulin

School of Nursing, Southern Medical University

gyl@i.smu.edu.cn+86 186 7587 2518

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026